Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • th3k33p3r24 th3k33p3r24 Sep 26, 2012 1:08 PM Flag

    THERE IS NO PRICE TARGET FROM AEGIS CAPITAL!!! MUST BE "YOUR" PRICE TARGET! LOL

    And here are a cupel of more quotes from the report:

    "We utilize a discounted cash flow analysis supporting a risk-adjusted Net Present Value (rNPV) framework to derive our $11.00 price target. This approach is described further in the next section of the report."

    .....

    "Required Disclosures
    Price Target
    Our 18-month price target for AMPE is $11.00.
    Valuation Methodology
    We utilize a risk-adjusted Net Present Value (rNPV) analysis to determine our price target objective. Using a discounted cash flow analysis, we derive an rNPV-based total firm value of $500 million, which translates into a price per share of $11.00, assuming 49 million fully-diluted shares outstanding and $40 million in cash as of end-2013."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMPE
1.92-0.16(-7.69%)Feb 9 4:01 PMEST